NO952138L - Cefiximpreparat - Google Patents

Cefiximpreparat

Info

Publication number
NO952138L
NO952138L NO952138A NO952138A NO952138L NO 952138 L NO952138 L NO 952138L NO 952138 A NO952138 A NO 952138A NO 952138 A NO952138 A NO 952138A NO 952138 L NO952138 L NO 952138L
Authority
NO
Norway
Prior art keywords
weight
maximum
cefiximpreparat
cefixim
thickening
Prior art date
Application number
NO952138A
Other languages
English (en)
Norwegian (no)
Other versions
NO952138D0 (no
Inventor
Joachim Bolz
Gertraud Wagner
Eckhard Oelrich
Dirk Radtke
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO952138D0 publication Critical patent/NO952138D0/no
Publication of NO952138L publication Critical patent/NO952138L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO952138A 1994-05-31 1995-05-30 Cefiximpreparat NO952138L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4418957A DE4418957A1 (de) 1994-05-31 1994-05-31 Cefixim-Zubereitung

Publications (2)

Publication Number Publication Date
NO952138D0 NO952138D0 (no) 1995-05-30
NO952138L true NO952138L (no) 1995-12-01

Family

ID=6519407

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952138A NO952138L (no) 1994-05-31 1995-05-30 Cefiximpreparat

Country Status (25)

Country Link
US (1) US5776926A (da)
EP (1) EP0685232B1 (da)
JP (1) JPH07330607A (da)
KR (1) KR950031077A (da)
CN (1) CN1117383A (da)
AT (1) ATE190844T1 (da)
AU (1) AU694201B2 (da)
CA (1) CA2150442A1 (da)
CO (1) CO4410174A1 (da)
CZ (1) CZ138595A3 (da)
DE (2) DE4418957A1 (da)
DK (1) DK0685232T3 (da)
ES (1) ES2146265T3 (da)
FI (1) FI952629A7 (da)
GR (1) GR3033704T3 (da)
HU (1) HU218217B (da)
IL (1) IL113917A0 (da)
NO (1) NO952138L (da)
NZ (1) NZ272216A (da)
PE (1) PE18796A1 (da)
PL (1) PL308838A1 (da)
PT (1) PT685232E (da)
SK (1) SK72795A3 (da)
TW (1) TW301610B (da)
ZA (1) ZA954427B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE216887T1 (de) * 1996-02-29 2002-05-15 Fujisawa Pharmaceutical Co Beta-lactam-antibiotikum enthaltende tabletten und verfahren zu deren herstellung
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
BRPI0418769A (pt) * 2004-05-10 2007-10-09 Lupin Ltd composição farmacêutica compreendendo cefixima, processo para a preparação de uma forma de dosagem oral sólida compreendendo de partìculas de cefixima, método para conseguir bio-equivalência entre a forma de dosagem oral e uma suspensão e comprimido mastigável compreendendo cefixima
WO2007119249A2 (en) * 2006-04-13 2007-10-25 Lupin Limited Pharmaceutical compositions of cefixime
US9233112B2 (en) 2006-04-13 2016-01-12 Lupin Limited Pharmaceutical compositions of cefixime
CN103301068B (zh) * 2013-07-08 2014-09-10 广东彼迪药业有限公司 一种头孢克肟干混悬剂剂及其制备方法
WO2015007571A1 (en) * 2013-07-18 2015-01-22 Sandoz Ag Powder mixtures for antibiotic dry syrup formulations
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11173163B2 (en) * 2015-08-05 2021-11-16 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996355A (en) 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins

Also Published As

Publication number Publication date
CZ138595A3 (en) 1996-04-17
TW301610B (da) 1997-04-01
AU694201B2 (en) 1998-07-16
DE4418957A1 (de) 1995-12-07
US5776926A (en) 1998-07-07
DK0685232T3 (da) 2000-08-21
HU218217B (hu) 2000-06-28
CA2150442A1 (en) 1995-12-01
HUT74421A (en) 1996-12-30
PE18796A1 (es) 1996-06-04
CO4410174A1 (es) 1997-01-09
PL308838A1 (en) 1995-12-11
JPH07330607A (ja) 1995-12-19
NO952138D0 (no) 1995-05-30
HU9501570D0 (en) 1995-07-28
IL113917A0 (en) 1995-08-31
DE59508024D1 (de) 2000-04-27
GR3033704T3 (en) 2000-10-31
AU2033595A (en) 1995-12-07
ATE190844T1 (de) 2000-04-15
SK72795A3 (en) 1996-01-10
EP0685232A3 (de) 1996-05-08
FI952629L (fi) 1995-12-01
ZA954427B (en) 1996-01-24
PT685232E (pt) 2000-08-31
EP0685232B1 (de) 2000-03-22
NZ272216A (en) 1996-05-28
FI952629A7 (fi) 1995-12-01
ES2146265T3 (es) 2000-08-01
CN1117383A (zh) 1996-02-28
KR950031077A (ko) 1995-12-18
EP0685232A2 (de) 1995-12-06
FI952629A0 (fi) 1995-05-30

Similar Documents

Publication Publication Date Title
NO952138L (no) Cefiximpreparat
GB2277179B (en) Compression using small dictionaries with application to network packets
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
WO1995029842A3 (en) Main rotor system for helicopters
SI0773025T1 (en) New stable galenic formulations containing an acid-labile benzimidazol compound, and production process
EP0428913A3 (en) Coupled quantum well strained superlattice structure and optically bistable semiconductor laser incorporating the same
EP0489647A3 (en) N,o-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them
CA2337015A1 (en) Excipient
IL106300A0 (en) Flavor-enhancing composition containing colloidal silica,processes for the preparation and use thereof
NO952179L (no) Ispreparat som omfatter gass-celler
MX9304165A (es) Una composicion de psyllium-goma hidrocoloidal.
AU1714995A (en) Semiconductor device
AU8710091A (en) Railway axle with orientable wheels and variable width
MX9801690A (es) Composicion detergente que comprende polimero floculador de arcilla con tamaño de particula menor que 250 micras.
IE890275L (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
Mullee et al. Telecommunications quality of service: principles and management
Henneaux Quantization of gauge fields in gauges involving" extra ghosts"
WO2002072044A3 (fr) Composition solide contenant des particules solides dont au moins une partie de fibres
AU7253494A (en) Fiber composition, method of preparation and use
鲁圣国 et al. Preparation and Quantum Size Effect of Semiconductor CdS Doped Silica Glass 0-3 Nanocomposites Through sol-gel Process
Otsuki et al. INFLUENCES OF SILICA FUME ON THE DURABILITY OF CONCRETE(Japanese)
Tomohiro et al. Large-N expansion and softly broken supersymmetry
AU7253394A (en) Dietary fiber composition, method of preparation and use
MUKHERJEE et al. Ultrapure glass optical waveguide: Development in microgravity by the sol gel process[Annual Progress Report]
Sprecher TGL 32610/01 to/03 and/06--New Standards for Limiting, Measuring and Rating Health-Hazardous Products Including Welding Fumes and Gases